Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K983110
    Date Cleared
    1999-02-25

    (174 days)

    Product Code
    Regulation Number
    892.1000
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Imaging of:

    • The Whole Body (including head, abdomen, breast, heart, pelvis, joints, neck, TMJ, spine, blood vessels, limbs, and extremities). [Application terms include MRCP (MR Cholangiopancreatography), MR Urography, MR Myelography, MR Fluoroscopy, SAS (Surface Anatomy Scan), Dynamic Scan, Cine Imaging, and Cardiac tagging.]
    • Fluid Visualization
    • 2D/3D Imaging
    • MR Angiography/MR Vascular Imaging
    • Blood Oxygenation Level Dependent (BOLD) Imaging
    Device Description

    This submission consists of a software upgrade to the MRT-50GP/E2 (FLEXARTTM), MRT-50GP/H2 (FLEXARTTM/Hyper), MRT-150/F1 (VISARTTM), MRT-150/F2 (VISARTTM/Hyper)

    AI/ML Overview

    Here's an analysis of the provided 510(k) summary relating to acceptance criteria and the study conducted:

    Disclaimer: The provided document (K983110) is a 510(k) Premarket Notification summary from 1998 for a software upgrade to existing Magnetic Resonance Diagnostic Devices (FLEXART™ and VISART™). It focuses on demonstrating substantial equivalence to previously cleared devices. It primarily discusses safety parameters and imaging performance specifications rather than a typical clinical study with acceptance criteria for a new AI/CAD device.

    This document predates widespread AI in medical imaging and the standard AI/CAD study structure. Therefore, many of the requested fields (like sample size for test/training sets, ground truth establishment methods, MRMC studies, effect sizes, and standalone performance) are not directly addressed in the provided text as they pertain to a different type of device evaluation.


    1. Table of Acceptance Criteria and Reported Device Performance

    Given the nature of the document, the "acceptance criteria" are more akin to specifications that the software upgrade maintains, and the "reported device performance" indicates that these specifications are met or comparable to the predicate devices.

    Parameter/CriteriaAcceptance Criteria (V3.5 s/w)Reported Device Performance (V4.0 s/w)Outcome/Met?
    Safety Parameters
    Maximum static field strength (FLEXART™)0.5 T0.5 TMet
    Maximum static field strength (VISART™)1.5 T1.5 TMet
    Rate of change of magnetic field (FLEXART™)11 T/sec.11 T/sec.Met
    Rate of change of magnetic field (FLEXART™/Hyper)13.3 T/sec.13.3 T/sec.Met
    Rate of change of magnetic field (VISART™)13.3 T/sec.13.3 T/sec.Met
    Rate of change of magnetic field (VISART™/Hyper)19.5 T/sec.19.5 T/sec.Met
    Maximum RF power deposition (FLEXART™)<0.4 W/kg<0.4 W/kgMet
    Maximum RF power deposition (VISART™)<1.0 W/kg<1.0 W/kgMet
    Acoustic noise levels (FLEXART™)100.2 dB(A)100.2 dB(A)Met
    Acoustic noise levels (FLEXART™/Hyper)98.5 dB(A)98.5 dB(A)Met
    Acoustic noise levels (VISART™)105.3 dB105.3 dBMet
    Acoustic noise levels (VISART™/Hyper)105.1 dB105.1 dBMet
    Imaging Performance Parameters
    Specification volume: Head16cm dsv16cm dsvMet
    Specification volume: Body28cm dsv28cm dsvMet
    Functionality: New sequences (e.g., cardiac tagging, Cine imaging)Not explicitly listed as "acceptance criteria" but included as new features"Sample clinical images are presented for new sequences" and substantial equivalence claimed.Implied Met

    2. Sample Size Used for the Test Set and Data Provenance

    The document does not specify a distinct "test set" in the context of an algorithmic performance evaluation. The evaluation primarily relies on:

    • Engineering specifications and measurements: For safety and imaging performance parameters (e.g., static field strength, SAR, acoustic noise, specification volume).
    • Demonstration of "Sample clinical images": For new sequences. The number of images or patients is not specified.
    • Comparison to predicate devices: The core of a 510(k) submission is to show substantial equivalence.

    Data Provenance: Not explicitly stated, however, the manufacturing site is "Toshiba Corporation, Japan". The context suggests data would likely be from internal testing and validation, potentially clinical data from relevant medical sites if "sample clinical images" implies actual patient scans. It is retrospective in the sense that it's comparing against existing cleared versions.


    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications

    This information is not provided in the document. The evaluation focuses on engineering specifications and "sample clinical images" which are presented, but details on expert review or ground truth establishment are absent.


    4. Adjudication Method for the Test Set

    This information is not provided in the document. Given the type of submission (software upgrade, substantial equivalence), a formal adjudication process for a clinical test set is not explicitly mentioned as being part of the presented summary.


    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and Effect Size

    A Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not reported or described in the provided document. The submission is a 510(k) for a software upgrade, demonstrating substantial equivalence, not a comparative effectiveness study comparing human readers with and without AI assistance.


    6. If a Standalone Performance Study Was Done

    A standalone performance study in the context of evaluating an algorithm only without human-in-the-loop performance was not described or reported. This submission concerns a software upgrade to an MRI device, not an AI or CAD algorithm.


    7. The Type of Ground Truth Used

    The "ground truth" for this submission primarily consists of:

    • Engineering measurements and specifications: For safety and scanner performance parameters (e.g., measured static field strength, SAR, acoustic noise, image volume).
    • Clinical observation/demonstration: "Sample clinical images" are presented to show the functionality and quality of new sequences. The specific type of "ground truth" for these images (e.g., pathology, clinical follow-up) is not specified.

    8. The Sample Size for the Training Set

    The concept of a "training set" in the context of machine learning is not applicable to this document. This submission does not describe an AI or machine learning device that requires a training set. It's a software upgrade to an existing MRI system.


    9. How the Ground Truth for the Training Set Was Established

    As stated in point 8, the concept of a "training set" is not applicable to this submission.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1